90 Day Jump Start Vision Program

Subscribe & Save

Guaranteed Safe Checkout

BENEFITS OF THE PROGRAM

  • Same program length as clinical study for optimal results.
  • Healthy eyes contain high levels of the natural antioxidant L-Carnosine. Interestingly, the eyes of those suffering from degenerative ocular diseases such as Cataracts were found to be highly deficient in L-Carnosine. Can-C™ Eye Drops help counter oxidation in the eyes and provide targeted nutrient support for those who suffer from Cataracts, Glaucoma, Floaters, AMD and Dry Eye.
  • The prime ingredient in Can-C™ is a proprietary form of N-Acetyl-Carnosine (NAC), which acts as both a stabilizer and carrier for L-Carnosine, safely delivering it into the fluid area of the eye surrounding the lens, allowing Carnosine to access the areas it needs to in order to act as a natural and highly effective antioxidant that protects and heals the eye from Cataracts and other ocular disease.
  • Years of research went into identifying the optimal purity factor of N-Acetyl-Carnosine (NAC) to ensure safety as well as optimal and long term results. This purity level is proprietary to our Can-C™ N-Acetyl-Carnosine Eye Drops, so look for the approved Can-C™ hologram on the box of any Can-C™ eye drop product prior to applying to the eyes.
  • Nac-C Plus™ Capsules synergistically compliment the action of Can-C™ Eye Drops’ by boosting specific amino acids that help to extend the activity (half-life) of Can-C eye drops thereby speeding up the overall healing response. In addition, Nac-C Plus™ Capsules ensure that an optimal balance of these powerful amino acids is maintained from a systemic pathway.
  • Nac-C Plus™ Capsules work together with Can-C™ Eye Drops to support and speed up the healing process by enhancing DNA repair, and further reducing oxidative stress that could otherwise inhibit or slow down the natural healing process. These capsules include specific antioxidants, and amino acids that have been clinically proven to improve vision and fight degenerative eye diseases like Cataracts and Glaucoma.
  • Ingredients in Nac-C Plus™ Capsules like N-Acetyl-Cysteine, L-Histidine, and L-Carnosine have been show to work synergistically to improve vision by increasing glutathione levels and acting as antioxidants to spare the lens of the eye from oxidative stress. Vitamin E and Zinc have also been shown to decrease risk of Cataracts and other age-related eye disease such as Glaucoma and Macular Degeneration.
  • For Best Results
  • Research
  • FAQs
  • Reviews

A higher (loading) dose of Can-C™ Eye Drops is recommended in the first few months of use to quickly re-establish optimal N-Acetyl-Carnosine (NAC) levels in the eyes; two drops applied in the morning to each eye (4 drops total) and two drops in the evening to each eye (4 drops total). The quicker these levels can be elevated in your eyes the sooner you will begin to see visual improvements. This initial (loading dosing period) lasts anywhere from 3 to 6 months depending upon the severity of your eye condition.

Once you begin to see notable improvements in brightness and clarity you may be confident that you have effectively re-established optimal NAC levels in your eyes, but the improvements don’t stop there. The good news is that once the NAC levels have been re-established to optimal levels in the eyes it is very easy to keep them there at half the cost. After three to six months of consistent use, only half the recommended Can-C dose is needed to effectively maintain these new levels, and the vision improvements will continue.

While many report visual improvements in as little as three months’ time, generally the most dramatic improvements will be reached between six and twelve months of consistent use. Once optimal results have been achieved, the maintenance dose of only one to two drops daily will prevent the return of the Cataracts and continue to support and improve the health of your eyes.

The benefits of Can-C™ are long-lasting, however if the drops are discontinued, the same deficiency that allowed the ocular condition to form in the first place will likely return again. Fortunately, by simply using a minimal amount of the product consistently, the good results can be maintained at less than half the initial cost.

Can-C™ eye drops initial loading-dose: two drops applied in the morning to each eye (4 drops total) and two drops in the evening to each eye (4 drops total).

Can-C™ eye drops maintenance Dose: After 3 to 6 months of use you will only need to use 1-2 drops of Can-C™ in each eye daily, with a one week pause from use every two months. The product will last a very long time at this level of usage.

Advanced Program Protocol
Nac-C Plus™ Capsules dose: take 3 capsules daily Nac-C Plus™ Capsules. When used in conjunction with Can-C™ eye drops, Nac-C Plus capsules increase the length of time that Can-C™ eye drops stay active in the eye by inhibiting the breakdown of the L-carnosine that has been topically administered through the drops. This sustained effect significantly enhances free radical protection and decreases the oxidative environment within the eye, allowing for a faster healing response.

Independent clinical results are based on consistent daily use.

CLINICAL STUDY

Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants

Study: Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants
Publication: Invest Ophthalmol Vis Sci . 2008 Apr;49(4):1447-58. doi: 10.1167/iovs.07-1361.
Date published: February 2, 2022
Authors: Yuan He, Kar Wah Leung, Yue-Hong Zhang, Shan Duan, Xiu-Feng Zhong, Ru-Zhang Jiang, Zhan Peng, Joyce Tombran-Tink, Jian Ge
Summary: Purpose: There is growing evidence that oxidative stress contributes to the progression of primary open-angle glaucoma (POAG), a leading cause of irreversible blindness worldwide. The authors provide evidence that mitochondrial dysfunction is a possible mechanism for the loss of trabecular meshwork (TM) cells in persons with POAG. Methods: TM from patients with POAG (GTM) and age-matched subjects without disease (NTM) were obtained by standard surgical trabeculectomy. Primary TM cultures were treated with one of the following mitochondrial respiratory chain inhibitors: rotenone (ROT, complex I inhibitor), thenoyltrifluoroacetone (TTFA, complex II inhibitor), myxothiazol or antimycin A (MYX, AM-complex III inhibitors); mitochondrial permeability transition (MPT) inhibitor cyclosporine A (CsA); and antioxidants vitamin E (Vit E) or N-acetylcysteine (NAC). Mitochondrial function was determined by changes in mitochondrial membrane potential (DeltaPsim) and adenosine triphosphate (ATP) production with the fluorescent probes 5,5′,6,6′-tetrachloro-1,1’3,3′-tetraethylbenzimid azolocarbocyanine iodide (JC-1) and a luciferin/luciferase-based ATP assay, respectively. Reactive oxygen species (ROS) level, determined by H(2)-DCF-DA, and cell death, measured by lactate dehydrogenase activity and Annexin V-FITC labeling, were also examined. Results: GTM cells have higher endogenous ROS levels, lower ATP levels, and decreased Delta Psi m and they are more sensitive to mitochondrial complex I inhibition than their normal counterparts. ROT induces a further increase in ROS production, the release of cytochrome c, and decreases in ATP level and Delta Psi m in GTM cells, eventually leading to apoptosis. Complex II and III inhibition had little effect on the cells. Antioxidants protect against ROT-induced death by inhibiting ROS generation and cytochrome c release. Conclusions: The authors propose that a mitochondrial complex I defect is associated with the degeneration of TM cells in patients with POAG, and antioxidants and MPT inhibitors can reduce the progression of this condition.

CLINICAL STUDY

Independent Study finds specific Amino Acids and Anti-Oxidants provide targeted support for those who suffer from IOP and Glaucoma.

Study: Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants
Publication: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1447-58. doi: 10.1167/iovs.07-1361.
Date published: January 24, 2022
Authors: Yuan He 1, Kar Wah Leung, Yue-Hong Zhang, Shan Duan, Xiu-Feng Zhong, Ru-Zhang Jiang, Zhan Peng, Joyce Tombran-Tink, Jian Ge
Summary: This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally noted is that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients. A key suspect in the progression of POAG is local oxidative stress. Oxidative free radicals and reactive oxygen species (ROS) are reported to trigger degeneration in the trabecular meshwork, subsequently leading to increases in IOP and glaucoma.

“Reversing oxidation may facilitate a healing response in the trabecular mesh-work or outflow pathway in the eyes of glaucoma patients.”

“There is nothing, that we know of, more effective than topically delivered N-acetyl-carnosine Can-C™ to reverse oxidation in the ocular environment” – Dr. Mark Babizhayev MA PhD

This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally noted is that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients.

What if I just want to improve the health of my eyes?

The dose for general eye health support and prevention is half the recommended dose for cataract reversal. Apply only two drops daily to each eye.

When will I begin to notice initial changes or improvements?
Typically, you will begin to see signs of initial results after the first 90 days of the recommended daily dosage. Results are more significant after 4 to 5 months and even more, dramatic results are achieved after 6 to 8 months. Because cataracts, and most other age-related eye disorders, are caused by low anti-oxidant and high free-radical activity, the regular and consistent use of Can-C™ has been shown to be an excellent, non-invasive option, for the treatment and even reversal of cataracts and other eye conditions.

Are there any vitamins or supplements that conflict with Can-C?

Yes, there are two; Lutein and Zeaxanthin. While in most cases taking vitamin supplements in no way conflict with the good effects of Can-C™ eye drops, Lutein and Zeaxanthin in the supplement form can be too much of a good thing as their pathway of action is the same as CanC. Please note that Can-C with N-acetyl carnosine is far more direct in its ability to address the problem of cataract and if combined with Lutein and Zeaxanthin can create a sort of imbalance that is not optimal. Lutein and Zeaxanthin can still be consumed in foods as it is only in supplement form that they are contraindicated. Once optimal results have been achieved and the lower maintenance dose of 1 drop daily is being used, Lutein and/or Zeaxanthin supplements may be re-introduced as part of the overall ocular health management effort. All other antioxidants and supplements can be continued and may certainly be of benefit to the end result.

Hello, I have been using your Can-C eye drops for 6 months to address a very newly diagnosed cataract. I haven't returned to the eye doctor yet but the interesting improvement is that my irritating floaters appear to have completely vanished. I almost had forgotten about them entirely because they were no longer in my vision and then one day I realized that they were not there! This is truly amazing and I am now very anxious to learn what my doctor has to say about my cataract. I truly want to thank you!* Carol B. Huntersville N.C.
Good news to report! It is too good for words. I have been using the eye drops for a month for cataracts in both of my eyes. The first thing I noticed was that lights seem brighter and have noticed that print is easier to read. I am near-sighted also, so being able to see numbers more clearly on a hymn board across the room is very exciting! I am hoping for more clarity as I continue to use the drops. This is too good to be true but it really is!* BB London
Dear Leslie, I am writing to let you know that I have been using Can-C to address a cataract in my right eye for a little more than 6 months and want to check with you as I am now ready to start with the maintenance dose of 1 drop a day. Earlier this year I had been noticing growing cloudiness in my vision and when I went to my eye doctor about 7 months ago March of 2007 I was diagnosed with a cataract in my right eye. I immediately went online and began researching and found Wise Choice Medicine and began using your Can-C eye drops daily as recommended. I didn't see much improvement at first but now I am amazed as my vision has progressively become clearer and clearer and today it is crystal clear in that eye. In addition to being overjoyed with the amazing improvement in my eyesight, it is fantastic to have invested in something that actually does what it says it will. I am sure that I will be a lifetime customer as you guys have an amazing product and I for one certainly want to thank you for it.* Sol H. New Jersey

Welcome to the shiny new WiseChoiceMedicine.com!

Finding the best vision support solutions has never been easier thanks to side-by-side program comparisons and access to the extensive clinical research supporting our products.

For any questions please contact our helpful and knowledgable support team at 1-800.861.4936